DESIGN AND DEVELOPMENT OF NOVEL ORILISTAT CHEWABLE TABLETS FOR THE TREATMENT OF OBESITY
Sathya Surya Prasad Ch.*, J. Vijaya Ratna, M. Mohan Varma
Abstract
Today in the world at the pharmacy plays a vital and critical role in
deciding the major studies of obesity and mortality fail to show that
overall obesity leads to greater risk. Orlistat is a novel, nonsystemically
acting anti-obesity agent used to treat obesity by
preventing the absorption of fats from the human diet, thereby
reducing caloric intake. The formulation tablet is a very complex
process. Because of manufacturing defects due to low melting point
sticky nature of the powder and stability of the API is poor. Now it’s
challenging task to obtain in tablet dosage form a new pharmaceutical
form with acceptable organoleptic properties and stable dosage form
for batter therapeutic action. The chewable tablets were prepared by
melt granulation technique by using different fatty acids. And FT-IR,
Differential scanning calorimetry, X-Ray diffraction and scanning
electron microscopy were performed to identify the physicochemical interaction between
drug and carriers.
Keywords: Orlistat, chewable tablets, melt granulation method, fatty acids.
[Full Text Article]